I

I Sens Inc
KOSDAQ:099190

Watchlist Manager
I Sens Inc
KOSDAQ:099190
Watchlist
Price: 27 000 KRW 6.09%
Market Cap: ₩745.5B

Gross Margin

38.1%
Current
Declining
by 1.3%
vs 3-y average of 39.3%

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
38.1%
=
Gross Profit
₩119.1B
/
Revenue
₩313.1B

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
38.1%
=
Gross Profit
₩119.1B
/
Revenue
₩313.1B

Peer Comparison

Country Company Market Cap Gross
Margin
KR
I Sens Inc
KOSDAQ:099190
744.8B KRW
Loading...
US
Abbott Laboratories
NYSE:ABT
200.1B USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
174.7B USD
Loading...
US
Stryker Corp
NYSE:SYK
146.9B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
126.6B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
110.4B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
47.2B EUR
Loading...
US
Becton Dickinson and Co
NYSE:BDX
52.7B USD
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
49.9B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
48B USD
Loading...
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
38.3B USD
Loading...

Market Distribution

Higher than 76% of companies in Korea
Percentile
76th
Based on 2 511 companies
76th percentile
38.1%
Low
-646.5% — 12.8%
Typical Range
12.8% — 32.2%
High
32.2% — 54 001.3%
Distribution Statistics
Korea
Min -646.5%
30th Percentile 12.8%
Median 19.7%
70th Percentile 32.2%
Max 54 001.3%

I Sens Inc
Glance View

Market Cap
745.5B KRW
Industry
Health Care

i-SENS, Inc. engages in development and manufacture of medical, environmental, industrial sensors. The company is headquartered in Seoul, Seoul. The company went IPO on 2013-01-30. The Company’s products consist of blood glucose monitoring systems, including blood glucose monitors, blood glucose meters, glucose monitors, blood glucose meter kits and blood sugar meters under the brand names of CareSens, MedTrust, BGStar, Barozen and others; electrolyte analyzers and cartridges; immunosensors, as well as other related accessories, such as connectors, lancets, blood glucose data management software and lancing devices, among others. The firm distributes its products within domestic market and to overseas markets including Japan, Europe, the United States and others.

I Sens Inc Intrinsic Value
HIDDEN
Show
What is Gross Margin?
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
How is Gross Margin calculated?

Gross Margin is calculated by dividing the Gross Profit by the Revenue.

Gross Margin
38.1%
=
Gross Profit
₩119.1B
/
Revenue
₩313.1B
What is I Sens Inc's current Gross Margin?

The current Gross Margin for I Sens Inc is 38.1%, which is below its 3-year median of 39.3%.

How has Gross Margin changed over time?

Over the last 3 years, I Sens Inc’s Gross Margin has decreased from 40.2% to 38.1%. During this period, it reached a low of 38.1% on Sep 30, 2025 and a high of 40.7% on Sep 30, 2024.

Back to Top